Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA
Clinical trial NCT01993641 · COMPLETED
Trial details
- NCT number
- NCT01993641
- Sponsor
- Helsinn Healthcare SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2015-05-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.